Riskpilot← Back to searchSign inGet full accessLægehuset 39-41 ApS
APSActiveCVR 25602900Strandgade 79, 1. 2Rental and operating of own or leased real estate · NACE 6820Est. 2000— employees
Revenue 2025
DKK 1,8M
+2% vs 2024
EBITDA margin
100.0%
+2% vs 2024
Equity ratio
50.2%
Financial strength
Net profit 2025
DKK 1,1M
+2% vs 2024
| Revenue | DKK 1,8M | +2% |
| EBITDA | DKK 1,8M | +2% |
| Net profit | DKK 1,1M | +2% |
| Total assets | DKK 34,7M | -1% |
| Equity | DKK 17,4M | +7% |
| Employees | — | — |
Legal name
Lægehuset 39-41 ApS
CVR number
25602900
Legal form
Anpartsselskab
NACE code
6820 · Rental and operating of own or leased real estate
Founded
7. september 2000
Share capital
DKK 500.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af 1 direktør.
Company purpose
Selskabets formål er at eje, udleje og administrere fast ejendom samt at foretage investering og anden dermed beslægtet virksomhed.
Address
Strandgade 79, 1. 2
Email
bo@bojepedersen.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 561 | 878 | 721 | 911 | 341 | 313 | 787 | 623 | 1.868 | 1.798 | 1.399 | 1.389 | 1.766 | 1.800 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 349 | 878 | 721 | 911 | 341 | 865 | 787 | 1.623 | 2.726 | 3.575 | 1.399 | 1.389 | 1.766 | 1.800 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 349 | 878 | 721 | 911 | 341 | 865 | 787 | 1.623 | 2.726 | 3.575 | 1.399 | 1.389 | 1.766 | 1.800 |
| Net financials | -396 | -379 | -343 | -325 | -320 | -324 | -174 | -158 | -202 | -308 | -329 | -439 | -369 | -671 |
| Profit before tax | -47 | 499 | 378 | 586 | 21 | 541 | 612 | 1.466 | 2.524 | 3.267 | 1.070 | 950 | 1.396 | 1.418 |
| Tax | 21 | 105 | 73 | 119 | -13 | -27 | 110 | 133 | 555 | 719 | 237 | 209 | 307 | 312 |
| Net profit | -68 | 394 | 305 | 467 | 34 | 568 | 502 | 1.332 | 1.969 | 2.548 | 833 | 741 | 1.089 | 1.106 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 11.630 | 11.757 | 11.812 | 12.070 | 12.420 | 12.678 | 12.800 | 13.631 | 30.842 | 34.968 | 34.846 | 36.306 | 34.983 | 34.708 |
| Equity | — | 450 | 755 | 1.222 | 1.256 | 1.817 | 2.319 | 3.651 | 11.096 | 13.644 | 14.477 | 15.218 | 16.307 | 17.414 |
| Long-term debt | 6.974 | 6.974 | 6.974 | 6.974 | 6.974 | 6.974 | 6.974 | 6.559 | 19.484 | 9.363 | 8.771 | 8.271 | 7.846 | 7.373 |
| Short-term debt | 8.086 | 7.819 | 7.253 | 7.036 | 7.321 | 7.017 | 6.631 | 6.248 | 8.361 | 10.428 | 10.024 | 11.224 | 9.196 | 8.249 |
| Total debt | 15.060 | 14.793 | 11.057 | 10.848 | 14.295 | 13.991 | 13.605 | 12.807 | 27.845 | 19.790 | 18.795 | 19.495 | 17.042 | 15.622 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122025
Equity ratio
50.2%
This company
38.2%
Market median
+31% vs market
20122025
Return on equity
6.4%
This company
18.4%
Market median
-65% vs market
20122025
Net profit margin
61.4%
This company
8.1%
Market median
+658% vs market
20122025
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20122025
Debt / equity
0.99×
This company
0.62×
Market median
+60% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BB Management | Management | 2000 | — | — |
| Audit | 2006 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
BØJE EJENDOM ApS | Company | 100.0% | 100.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BØJE HOLDING ApS
Lægehuset 39-41 ApS Board members of Lægehuset 39-41 ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Bøje Pedersen | Management | 0 companies |
| ND Revision Slagelse Registreret Revisionsaktie- selskab | Audit | 0 companies |